[{"Assets_0_Q2_USD":381084000.0,"CommonStockSharesOutstanding_0_Q2_shares":149021.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-85281000.0,"NetIncomeLoss_1_Q2_USD":-41624000.0,"NetIncomeLoss_2_Q2_USD":-80237000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":89190000.0,"Ticker":"IMGN","CIK":"855654","name":"IMMUNOGEN INC","OfficialName":"ImmunoGen Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1148965984.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180803"}]